For years, doctors have been stumped by Alzheimer’s. What really causes it? And why do some people’s memories fade so quickly while others stay sharp? A new study out of the University of Virginia may have uncovered a surprising piece of the puzzle – and it all starts with the brain’s own defense system.
Here’s the twist: the culprit might not just be those famous sticky plaques and tangles. According to UVA researchers, an immune molecule called STING – normally tasked with protecting us – can go rogue. Instead of helping, it seems to kick off harmful brain inflammation as we age. That inflammation then drives the plaque buildup and nerve damage linked to Alzheimer’s and possibly other diseases like Parkinson’s and ALS.
When scientists blocked STING in lab mice, the results were striking. The mice kept their memories sharper, and their brain cells were less damaged. “DNA damage builds up naturally over time, and we’ve found that STING turns that damage into harmful inflammation,” explained Dr. John Lukens, who leads UVA’s Harrison Family Translational Research Center. “That might be why Alzheimer’s risk rises so steeply as we get older.”
And the need for answers is huge. Alzheimer’s already affects over 7 million Americans, and experts say that number could hit 13 million by 2050. Treatments are limited, and most only ease symptoms for a while. What makes STING interesting is that it seems to be involved early in the disease process and influences both amyloid plaques and tau tangles – the two hallmarks of Alzheimer’s. Most other drug targets only affect one or work during a narrow stage of the disease.
The UVA team also noticed that turning off STING calmed overactive immune cells called microglia, which are often seen surrounding amyloid plaques. That’s a big deal because these cells can either protect neurons or harm them depending on how fired up they are.
Of course, there’s a lot left to figure out. STING also plays important roles outside the brain, like helping fight infections and possibly cancer. Any drug aimed at it would need to be carefully designed to avoid unwanted side effects. But Lukens and his team believe the discovery is a major step. “If we can safely dial down STING’s harmful activity, we may have a shot at slowing or even preventing neurodegeneration,” Lukens said.
The findings, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, offer a new path for researchers racing to protect aging brains. It’s early days, but the hope is that this kind of immune-targeting therapy could eventually change the lives of millions of families worldwide.
Source: sciencedaily.com